Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve

EuroIntervention 2016;12:Y116-Y118. DOI: 10.4244/EIJV12SYA32

Hans R. Figulla
Hans R. Figulla1*, MD; Katharina Kiss2, MD; Alexander Lauten3, MD
1. Kerckhoff Heart Center, Bad Nauheim, Germany; 2. Intern Kardiologische Angiologische Gruppenpraxis, Vienna, Austria; 3. Department of Cardiology, Charité-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

Considering the incidence of tricuspid regurgitation (TR) and its implications on functional status and long-term survival, TR is currently undertreated. With the increasing adoption of catheter-based treatments of other type

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for valvular diseaseTricuspid / Pulmonary valveTools, devices and techniques
Read next article
Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign

Latest news